Amundsen SF, Stamnaes J, du Pré MF, Sollid LM(2022) Transglutaminase 2 affinity and enzyme-substrate intermediate stability as determining factors for T-cell responses to gluten peptides in celiac disease Eur J Immunol(in press) DOI 10.1002/eji.202249862, PubMed 35715890
Klaasen RA, Warren DJ, Iversen R, Bolstad N, Andersen IL, Mjønes P, Rønne E, Lundin KEA, Sollid LM, Ness-Jensen E(2022) The development and validation of a high-capacity serological assay for celiac disease Clin Biochem(in press) DOI 10.1016/j.clinbiochem.2022.05.010, PubMed 35660483
Lindstad CB, du Pré MF, Stamnaes J, Sollid LM(2022) Injection of prototypic celiac anti-transglutaminase 2 antibodies in mice does not cause enteropathy PLoS One, 17(4), e0266543 DOI 10.1371/journal.pone.0266543, PubMed 35385534